Edition:
United States

Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

209.47USD
19 Jul 2019
Change (% chg)

$-4.95 (-2.31%)
Prev Close
$214.42
Open
$214.71
Day's High
$215.97
Day's Low
$209.23
Volume
113,650
Avg. Vol
61,590
52-wk High
$217.11
52-wk Low
$132.75

Latest Key Developments (Source: Significant Developments)

Bio-Techne Acquires B-Mogen Biotechnologies Inc
Tuesday, 4 Jun 2019 05:30pm EDT 

June 4 (Reuters) - Bio-Techne Corp ::BIO-TECHNE TO ACQUIRE B-MOGEN BIOTECHNOLOGIES INC.BIO-TECHNE CORP - DEAL HAS BEEN COMPLETED AND IS BEING FINANCED THROUGH AVAILABLE CASH ON HAND.  Full Article

Elpiscience and Bio-Techne Announce Strategic Collaboration
Monday, 22 Apr 2019 09:15am EDT 

April 22 (Reuters) - Bio-Techne Corp ::ELPISCIENCE AND BIO-TECHNE ANNOUNCE STRATEGIC COLLABORATION.BIO-TECHNE CORP - ELPISCIENCE WILL HAVE ACCESS TO MULTIPLE ANTIBODIES FROM BIO-TECHNE'S EXTENSIVE PRODUCT PORTFOLIO.  Full Article

Bio-Techne Signs Strategic Cooperation Agreement With Lisen Imprinting Diagnostics
Tuesday, 26 Feb 2019 01:19pm EST 

Feb 26 (Reuters) - Bio-Techne Corp ::BIO-TECHNE SIGNS STRATEGIC COOPERATION AGREEMENT WITH LISEN IMPRINTING DIAGNOSTICS.  Full Article

Bio-Techne Releases Second Quarter Fiscal 2019 Results
Tuesday, 5 Feb 2019 06:30am EST 

Feb 5 (Reuters) - Bio-Techne Corp ::BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2019 RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $1.06.Q2 GAAP EARNINGS PER SHARE $0.45.Q2 SALES $174.5 MILLION VERSUS REFINITIV IBES ESTIMATE OF $170.2 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.98 -- REFINITIV IBES DATA.Q2 ORGANIC REVENUE INCREASED BY 11% (13% REPORTED) TO $174.5 MILLION."PARTICULARLY IMPRESSED WITH CHINA" REGARDING PERFORMANCE IN QUARTER.  Full Article

Bio-Techne Releases First Quarter Fiscal 2019 Results
Tuesday, 30 Oct 2018 07:00am EDT 

Oct 30 (Reuters) - Bio-Techne Corp ::BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2019 RESULTS.Q1 ADJUSTED EARNINGS PER SHARE $0.98.Q1 GAAP EARNINGS PER SHARE $0.45.Q1 SALES $163 MILLION VERSUS I/B/E/S VIEW $161.9 MILLION.Q1 EARNINGS PER SHARE VIEW $0.95 -- THOMSON REUTERS I/B/E/S.  Full Article

Bio-Techne Signs Strategic Co-operation Agreement
Friday, 12 Oct 2018 08:30am EDT 

Oct 12 (Reuters) - Bio-Techne Corp ::BIO-TECHNE SIGNS STRATEGIC COOPERATION AGREEMENT WITH MICROPOINT BIOSCIENCE.BIO-TECHNE - CO, MICROPOINT BIOSCIENCE WILL FURTHER STRENGTHEN INTEGRATION OF MICROPOINT'S MICROFLUIDIC DIAGNOSTIC CHIP FOR POINT-OF-CARE TESTING.  Full Article

Bio-Techne Corp Completed Acquisition Of Exosome Diagnostics
Wednesday, 1 Aug 2018 04:15pm EDT 

Aug 1 (Reuters) - Bio-Techne Corp ::BIO-TECHNE CORPORATION COMPLETED ITS ACQUISITION OF EXOSOME DIAGNOSTICS, INC..  Full Article

Bio-Techne To Acquire Exosome Diagnostics Inc
Monday, 25 Jun 2018 04:09pm EDT 

June 25 (Reuters) - Bio-Techne Corp ::BIO-TECHNE TO ACQUIRE EXOSOME DIAGNOSTICS, INC..BIO-TECHNE CORP - DEAL FOR $250 MILLION IN CASH PLUS CONTINGENT CONSIDERATION OF UP TO $325 MILLION DUE UPON ACHIEVEMENT OF CERTAIN FUTURE MILESTONES.BIO-TECHNE CORP - DEAL TO BE FINANCED USING CASH ON HAND & A REVOLVING LINE OF CREDIT FACILITY THAT CO EXPECTS TO OBTAIN PRIOR TO CLOSING OF DEAL.  Full Article

Bio-Techne Acquires Atlanta Biologicals Inc
Tuesday, 2 Jan 2018 05:01pm EST 

Jan 2 (Reuters) - Bio-Techne Corp ::BIO-TECHNE ACQUIRES ATLANTA BIOLOGICALS INC.BIO-TECHNE CORP - ‍TRANSACTION IS FINANCED THROUGH AVAILABLE CASH ON HAND​.BIO-TECHNE - DEAL EXPECTED TO BE SLIGHTLY ACCRETIVE TO ADJUSTED EARNINGS PER SHARE FOR FISCAL YEAR 2018.  Full Article

Bio-Techne releases Q1 adjusted earnings per share $0.90
Tuesday, 31 Oct 2017 07:35am EDT 

Oct 31 (Reuters) - Bio-Techne Corp :Bio-Techne releases first quarter fiscal 2018 results.Q1 adjusted earnings per share $0.90.Q1 GAAP earnings per share $0.42.Q1 sales $144.6 million versus I/B/E/S view $142.9 million.Q1 earnings per share view $0.88 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Roche Expands Partnership With Bio-Techne To Offer Drug Discovery Researchers New Chromogenic Detection Options For Mrna Ish Tissue Analysis

* ROCHE EXPANDS PARTNERSHIP WITH BIO-TECHNE TO OFFER DRUG DISCOVERY RESEARCHERS NEW CHROMOGENIC DETECTION OPTIONS FOR MRNA ISH TISSUE ANALYSIS